- Home
- DPG vs BVS Comparison
DPG vs BVS Comparison
Compare DPG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DPG | BVS |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.9M | 482.9M |
| IPO Year | 2011 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DPG | BVS |
|---|---|---|
| Price | $14.96 | $8.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.33 |
| AVG Volume (30 Days) | 114.0K | ★ 253.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.12 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $573,280,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.78 |
| P/E Ratio | ★ N/A | $73.25 |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $10.45 | $5.81 |
| 52 Week High | $14.90 | $11.25 |
Technical Indicators
Market Signals| Indicator | DPG | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 80.05 | 63.49 |
| Support Level | $12.37 | $6.37 |
| Resistance Level | N/A | $9.03 |
| Average True Range (ATR) | 0.22 | 0.34 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 93.00 | 77.46 |
Price Performance
Historical ComparisonAbout DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting from a high level of current income, with an emphasis on providing tax-advantaged dividend income.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.